NCATS spotlights CTSI-supported opioid research
CTSI KL2 scholar John Mafi led the study
A CTSI-supported study led by CTSI KL2 scholar, John Mafi, and colleagues was highlighted as a top story in the August 2018 issue of the NIH NCATS Newsletter and as a featured story on the NCATS website.
The study, published in JAMA Psychiatry, discovered that patients taking a class of drug known to increase the risk for overdose were likelier to receive a first-time opioid prescription than the general population. Patients taking a class of anti-anxiety medications called benzodiazepines received first-time opioid prescriptions at the rate of 172 per 1,000 in 2015, more than double the rate of 79 per 1,000 in 2015 for the general population.
Further reading:
UCLA press release
Image caption: John Mafi (UCLA)
Image source: UCLA Health
Related Articles
Final NIH Training Grant Changes Released | Effective Jan. 25, 2025
Final instructions have been released for NRSA Training Grants submitted on or after January 25th, 2025.
Civic Science AI Fellow selected by Center for SMART Health and CTSI
Mackensie Yore, an emergency physician researching health equity and the importance of human connection in medicine, has been selected as the first fellow.
UC BRAID: A clinical trial pilot pioneers a new era of collaboration, innovation and equity
UC BRAID: A clinical trial pilot pioneers a new era of collaboration, innovation and equity
CTSI GSU Training Grant Team Open Office Hours
Join the UCLA CTSI Grant Submission Unit’s Training Grant Office Hours on select Thursday from 11am – 12pm.